Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HNRNPA1P10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HP1BP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBXA2R - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACOX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAQR8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRSF10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TSSK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PRR5L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOC6B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MOB1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
METTL6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BBS9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ULK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SVIL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on